FLT3 and acute myeloid leukemia: Specifically, the best inhibition ability of 1 was against the FMS-like tyrosine kinase 3 (FLT3) internal tandem duplication mutation of the gatekeeper residue F691 (FLT3-ITD, F691L) involved in acute myeloid leukemia, among others [34].